Thomas C. Gallagher

Corporate Officer/Principal bei GENPREX, INC.

Health Technology

Profil

Thomas C.
Gallagher is currently the Senior VP-Intellectual Property & Licensing at Genprex, Inc. He previously worked as the Vice President-Intellectual Property at ImClone LLC, Counsel at Caladrius Biosciences, Inc., and Senior VP-Intellectual Property & Licensing at Kadmon Corp.
LLC.

Aktive Positionen von Thomas C. Gallagher

Unternehmen	Position	Beginn
GENPREX, INC.	Corporate Officer/Principal	21.09.2020

Alle aktiven Positionen von Thomas C. Gallagher

Ehemalige bekannte Positionen von Thomas C. Gallagher

Unternehmen	Position	Ende
Kadmon Corp. LLC Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY.	Corporate Officer/Principal	-
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.	Corporate Officer/Principal	-
ImClone LLC ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Thomas C. Gallagher im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Thomas C. Gallagher im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
GENPREX, INC.	Health Technology

Private Unternehmen	3
ImClone LLC ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.	Health Technology
Kadmon Corp. LLC Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY.	Health Technology
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.	Health Technology

Sehen Sie sich die Unternehmensverbindungen an

Börse
Insiders
Thomas C. Gallagher